Total body hyperthermia in combination with etoposide and melphalan in a child with acute myelomonocytic leukemia.
暂无分享,去创建一个
[1] J. Krischer,et al. High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] W. Wilmanns,et al. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] F. Mandelli,et al. BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remission. , 1990, Blood.
[4] A. Neville,et al. Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable B-cell neoplasms: a report of two pilot clinical trials and laboratory investigations. , 1990, International journal of radiation oncology, biology, physics.
[5] V. Pai,et al. Autologous bone marrow transplantation (ABMT) in acute myelogenous leukaemia--Heidelberg experience. , 1990, The Journal of the Association of Physicians of India.
[6] P. Crilley,et al. Bone marrow transplantation following busulfan and cyclophosphamide for acute myelogenous leukemia. , 1990, Bone marrow transplantation.
[7] C. Song,et al. Thermal sensitivity and thermal tolerance of human B-lineage acute lymphoblastic leukemia (ALL) cells. , 1990, International journal of radiation oncology, biology, physics.
[8] P. Kovács,et al. Survival and characteristics of murine leukaemic and normal stem cells after hyperthermia: a murine model for human bone marrow purging. , 1990, Leukemia research.
[9] C. Greiner,et al. [Treatment of otherwise incurable tumor diseases in childhood using whole-body hyperthermia and chemotherapy]. , 2008, Deutsche medizinische Wochenschrift.
[10] C. Richman,et al. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia. , 1989, Experimental hematology.
[11] M. A. Tanner,et al. Interactions of thymidine, hyperthermia, and cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) in human T-cell leukemia. , 1989, Cancer research.
[12] M. Minegishi,et al. Effects of in vitro treatment with 4-hydroperoxycyclophosphamide and hyperthermia on leukemic progenitor cells. , 1989, The Tohoku journal of experimental medicine.
[13] R. Zittoun,et al. In vitro sensitivity of normal and leukemic myeloid clonogenic cells to hyperthermia: absence of selective effect. , 1989, Experimental hematology.
[14] N. Mivechi,et al. Enhancement of murine bone marrow ablation by combining whole body hyperthermia with total body irradiation and cyclophosphamide. , 1989, International journal of radiation oncology, biology, physics.
[15] J. Reiffers,et al. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial , 1989, British journal of haematology.
[16] P. Okunieff,et al. Response of tumour red blood cell flux to hyperthermia and/or hyperglycaemia. , 1989, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[17] Russell Higuchi,et al. Hyperthermic Effects In vitro on the Peripheral Lymphocytes Isolated from Three Cases of Malignant Lymphoma/Leukemia , 1989, The Journal of dermatology.
[18] W. Da,et al. Studies on sensitivity of human GM-CFU and L-CFU to hyperthermic killing in vitro. , 1989, Leukemia research.
[19] R. Willemze,et al. Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC Leukemia Cooperative Group phase II study. , 1988, European journal of cancer & clinical oncology.
[20] W. Berdel,et al. Purging of acute myeloid leukemic cells by ether lipids and hyperthermia. , 1988, Blood.
[21] Y. Baba,et al. Radiation and thermal characteristics of mouse lymphoma cells and their radiation-sensitive mutant. , 1988, Radiation medicine.
[22] H. Broxmeyer,et al. Effect of whole-body hyperthermia and cyclophosphamide on natural killer cell activity in murine erythroleukemia. , 1988, Cancer research.
[23] N. Bouck,et al. Interactions between hyperthermia and irradiation in two human lymphoblastic leukemia cell lines in vitro. , 1988, Cancer research.
[24] H. Robins,et al. A hyperthermia study of differential sensitivity and thermotolerance in AKR murine leukemia and normal bone marrow cells. , 1988, International journal of radiation oncology, biology, physics.
[25] H. Stützer,et al. The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma , 1988, Cancer.
[26] W. Hinkelbein,et al. Toxic effects of irradiation or doxorubicin in combination with moderate whole-body hyperthermia on bone marrow in rats. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[27] R. Davis,et al. Hyperthermia Potentiates the Activity of Immunotoxin Conjugates against Common Acute Lymphoblastic Leukaemia Cells in Vitro a , 1987, Annals of the New York Academy of Sciences.
[28] H. Robins,et al. Interaction of whole-body hyperthermia and irradiation in the treatment of AKR mouse leukemia. , 1987, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[29] Cohen Jd,et al. Hyperthermic Enhancement of cis-Diammine-1,1-cyclobutane Dicarboxylate Platinum(II) Cytotoxicity in Human Leukemia Cells in Vitro , 1987 .
[30] G. A. Alexander,et al. Modification of human tumor pH by elevation of blood glucose. , 1987, International journal of radiation oncology, biology, physics.
[31] T. A. Simpson,et al. Restoration of hyperthermia-associated increased protein to DNA ratio of nucleoids. , 1987, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[32] A. Juvekar,et al. In vitro modulation of adriamycin and mitoxantrone cytotoxicity by hyperthermia and diazepam, in human chronic myeloid leukemia cells. , 1987, Neoplasma.
[33] M. Dewhirst,et al. Whole body hyperthermia and heat-sensitizing drugs: a pilot study in canine lymphoproliferative disease. , 1987, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[34] M. Chitnis,et al. Potentiation of Adriamycin Cytotoxicity in P388 Murine Leukemia Sensitive and Resistant to Adriamycin by use of Lonidamine and Hyperthermia , 1986, Tumori.
[35] J. Bertino,et al. Cytotoxic effects of hyperthermia, 5-fluorouracil and their combination on a human leukemia T-lymphoblast cell line, CCRF-CEM. , 1986, European journal of cancer & clinical oncology.
[36] A. Juvekar,et al. Inhibition of DNA synthesis by lonidamine and hyperthermia in human chronic myeloid leukemia cells. , 1986, Anticancer research.
[37] K. Kishi,et al. Application of hyperthermia to the treatment of human acute leukemia: purging human leukemic progenitor cells by heat. , 1986, Blood.
[38] A. Juvekar,et al. Effect of mitoxantrone on human chronic myeloid leukemia cells in vitro, combined with hyperthermia. , 1986, Neoplasma.
[39] R. O'reilly. Allogenic bone marrow transplantation: current status and future directions. , 1983, Blood.
[40] R. Gelber,et al. Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update , 1983 .
[41] E. Krementz. Chemotherapy by isolated regional perfusion for melanoma of the limbs. , 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.